Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of bipolar disorder (type I) with manic or mixed episodes (including patients with/without psychotic features or with/without a history of rapid cycling)
In need of psychiatric treatment
Cooperation and willingness to complete all aspects of the study
You may not be if
Current diagnosis other than bipolar I disorder
History of schizophrenia or schizoaffective disorder
Drug dependence within 1 month prior to study start or testing positive in a urine drug test
Suicide attempt within 1 month prior to study start or at immediate risk of harm to self or others
Any form of psychotherapy within 1 month prior to study start
Clareo Health | Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
